Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Struggling with debt? Check out these ways to make money that can help you pay off debt and improve your financial situation.
22,254 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Two popular small-cap growth ETFs—ISCG and VBK—aim to capture the fast-growing corner of the U.S. market. This guide ...
Insiders are quietly loading up on fintech stocks even as markets wobble. This article explains what those moves coul...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
JPMorgan cuts McDonald’s price target to $305 amid softer same-store-sales, signaling a shift toward efficiency at ex...
A Latin American e-commerce and fintech stock posts 27 consecutive quarters of 30%+ revenue growth, defying geopoliti...
Quantum computing is edging toward mainstream impact, with a $72 billion forecast by 2035. This article uncovers thre...
Starting with $500 in crypto doesn't have to be chaotic. This guide shows a clear, actionable plan to pick the best c...
Tech leadership from Microsoft helped major indexes climb, even as headlines shifted. Learn what this means for portf...
As 2027 approaches, policymakers are weighing changes to Social Security that could affect retiree income. This artic...
AI-driven automation is reshaping tech hiring. While some roles shrink, new opportunities emerge in AI tooling, data ...
As the space economy expands, investors face a big question: spacex rocket lab: which stock deserves a place in a gro...